Full metadata record
DC FieldValueLanguage
dc.contributor.authorSleziona, Dominik-
dc.contributor.authorMattusch, Amelie-
dc.contributor.authorSchaldach, Gerhard-
dc.contributor.authorEly, David R.-
dc.contributor.authorSadowski, Gabriele-
dc.contributor.authorThommes, Markus-
dc.description.abstractThe dissolution behavior of novel active pharmaceutical ingredients (API) is a crucial parameter in drug formulation since it frequently affects the drug release. Generally, a distinction is made between surface-reaction- and diffusion-controlled drug release. Therefore, dissolution studies such as the intrinsic dissolution test defined in the pharmacopeia have been performed for many years. In order to overcome the disadvantages of the common intrinsic dissolution test, a new experimental setup was developed within this study. Specifically, a flow channel was designed and tested for measuring the mass transfer from a flat, solid surface dissolving into a fluid flowing over the surface with well-defined flow conditions. A mathematical model was developed that distinguishes between surface-reaction- and diffusion-limited drug release based on experimental data. Three different drugs—benzocaine, theophylline and griseofulvin—were used to investigate the mass flux during dissolution due to surface reaction, diffusion and convection kinetics. This new technique shows potential to be a valuable tool for the identification of formulation strategies.en
dc.subjectDrug releaseen
dc.subjectFlow channelen
dc.subjectIntrinsic dissolutionen
dc.subjectSurface reactionen
dc.subjectTwo-film theoryen
dc.titleDetermination of inherent dissolution performance of drug substancesen
dcterms.accessRightsopen access-
eldorado.secondarypublication.primarycitationSleziona, D.; Mattusch, A.; Schaldach, G.; Ely, D.R.; Sadowski, G.; Thommes, M. Determination of Inherent Dissolution Performance of Drug Substances. Pharmaceutics 2021, 13, 146.de
Appears in Collections:Lehrstuhl Feststoffverfahrenstechnik

Files in This Item:
File Description SizeFormat 
pharmaceutics-13-00146-v2.pdf2.61 MBAdobe PDFView/Open

This item is protected by original copyright

All resources in the repository are protected by copyright.